UT Health San Antonio receives NIH award to expand groundbreaking research capabilities

September 1, 2023

  The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) received a grant from the National Institutes of Health in excess of $590,000 that will be used to purchase a NanoWizard® 5 Atomic Force Microscope (NW5 AFM), the first of its class to be installed in San Antonio. […]

Mays Cancer Center conducts only clinical trial in America of a specific drug combination for lethal brain cancer glioblastoma

May 23, 2023

An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 23, 2023) — The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma […]

Molecule shows potential to combat treatment resistance in brain tumor glioblastoma

May 17, 2023

Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (May 17, 2023) — Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience therapy resistance leading to […]

Glioblastoma recurrence and clues to blunt it

November 8, 2021

Radiation that at first is beneficial later causes cells to senesce, promoting brain cancer’s return. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Nov. 8, 2021) — It’s a medical conundrum. Ionizing radiation, which at first extends the survival of glioblastoma patients after surgery, may later, ironically, help drive the brain cancer’s aggressive, untreatable recurrence. […]